MOXAVAL CL 375 combines Amoxicillin, a broad-spectrum penicillin antibiotic, with Potassium
Clavulanate, a β-lactamase inhibitor. This synergistic combination enhances Amoxicillin’s ability
to overcome resistance caused by β-lactamase-producing bacteria, ensuring effective treatment
for a variety of bacterial infections.

Key Benefits:
● Provides broad-spectrum coverage against both gram-positive and gram-negative
bacteria
● Effective against β-lactamase-producing resistant bacterial strains
● Ideal for treating a wide range of infections, including respiratory, urinary tract, and skin
infections
● Convenient dosage formulation for improved patient compliance
● Well-tolerated with a favorable safety profile

Indications:
● Respiratory tract infections (e.g., pneumonia, bronchitis, sinusitis)
● Urinary tract infections (e.g., cystitis, pyelonephritis)
● Skin and soft tissue infections (e.g., cellulitis, abscesses)
● Otitis media, tonsillitis, and other ENT infections